Journal of Immunological Methods

Journal

Publication Venue For

  • Measuring immune responses to pneumococcal vaccines.  461:37-43. 2018
  • Rapid and efficient purification of ficolin-2 using a disposable CELLine bioreactor.  424:106-110. 2015
  • Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.  409:161-173. 2014
  • Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.  409:147-160. 2014
  • The impact of Nucleofection® on the activation state of primary human CD4 T cells.  408:123-131. 2014
  • A rapid and quantitative method for the evaluation of V gene usage, specificities and the clonal size of B cell repertoires.  376:143-149. 2012
  • Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses.  369:115-124. 2011
  • An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform.  341:106-116. 2009
  • Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells.  340:42-47. 2009
  • Quantitative imaging assay for NF-κB nuclear translocation in primary human macrophages.  329:194-200. 2008
  • Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.  312:1-11. 2006
  • Simplified method to automatically count bacterial colony forming unit.  302:99-102. 2005
  • Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications.  285:265-280. 2004
  • Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles.  256:89-105. 2001
  • Quantitative analysis of Helicobacter pylori infection in a mouse model.  242:67-78. 2000
  • In situ hybridization analysis of immunoglobulin heavy chain variable gene expression with family specific oligonucleotide probes.  218:31-52. 1998
  • Consistent transient transfection of DNA into non-transformed human and murine T-lymphocytes.  205:145-150. 1997
  • Flow cytometric quantitation of attachment and phagocytosis in phenotypically-defined subpopulations of cells using PKH26-labeled FcγR- specific probes.  205:55-65. 1997
  • Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine.  202:1-11. 1997
  • Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative study.  193:103-148. 1996
  • Luminometry: A novel bioluminescent immunoassay enhances the quantitation of mucosal and systemic antibody responses.  190:189-197. 1996
  • Phosphatidylinositol hydrolysis in freshly isolated human T lymphocytes.  186:71-77. 1995
  • Conjugation of cholera toxin or its B subunit to liposomes for targeted delivery of antigens.  185:31-42. 1995
  • In situ hybridization for cytokine mRNA with digoxigenin-labeled riboprobes Sensitivity of detection and double label applications.  182:93-106. 1995
  • Cytokine-specific ELISPOT assay single cell analysis of IL-2, IL-4 and IL-6 producing cells.  160:181-189. 1993
  • Cellular enzyme-linked immunocircle assay. A rapid assay of hybridomas produced against cell surface antigens.  153:141-149. 1992
  • Kinetics of killing by monoclonal cytotoxic T lymphocytes. I. Colorimetric detection of cryptic CTL determinants on adherent target cells and survivorship analysis.  152:159-169. 1992
  • Receptor specific probes for the study of Fcγ receptor specific function.  148:179-187. 1992
  • A method for generating antigen-specific rat T helper cell clones.  138:77-86. 1991
  • Preparation of monoclonal antibodies to C3b by immunization with C3b(i)-Sepharose.  120:241-249. 1989
  • Characterization of liposome suspensions by flow cytometry.  119:135-143. 1989
  • A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells.  115:31-37. 1988
  • A method of obtaining, processing, and analyzing human intestinal secretions for antibody content.  110:85-91. 1988
  • Human IgG subclass assays using a novel assay method.  88:65-73. 1986
  • Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies.  87:87-93. 1986
  • An enzyme-linked immunosorbent assay (ELISA) for detection of Fcα receptors on isotype-specific T cells.  85:269-277. 1985
  • Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay.  67:303-309. 1984
  • A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions.  67:101-108. 1984
  • A plaque assay for assessment of immune responses to Streptococcus mutans cell wall carbohydrate.  59:381-388. 1983
  • An enzyme-linked immunoabsorbent assay for measuring antibodies against muscle acetylcholine receptor.  57:111-119. 1983
  • IgA hybridomas: A method for generation in high numbers.  54:259-266. 1982
  • A quantitative assay for IgA rheumatoid factor.  50:89-98. 1982
  • An enzymatic method for preparation of dissociated murine Peyer's patch cells enriched for macrophages.  48:33-44. 1982
  • Interleukin 1: Production by P388D1 cells attached to microcarrier beads.  46:197-204. 1981
  • Isoelectric focusing of immunoglobulins: Improved methodology.  33:101-115. 1980
  • pH gradient elution of human IgG1, IgG2 and IgG4 from protein A-Sepharose.  31:211-217. 1979
  • Detection of isoelectric focused antibody by autoradiography and hemolysis of antigen-coated erythrocytes. A comparison of methods.  8:363-372. 1975
  • International Standard Serial Number (issn)

  • 0022-1759
  • Electronic International Standard Serial Number (eissn)

  • 1872-7905